Observational studyNeurology(R) neuroimmunology & neuroinflammation2023

Efficacy of Rituximab Outlasts B-Cell Repopulation in Multiple Sclerosis: Time to Rethink Dosing?

Roxane Claverie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.